Glaxosmithkline Services Unlimited

Active01047315 Private unlimited company
Incorporated
23 March 1972 (54 years)
Industry
Activities of head offices (70100)
Directors
Owned by
Accounts type
Full
Region
Greater London
Address
79 New Oxford Street
London
WC1A 1DG

Filing status

Last accounts
31 December 2025
Conf. stmt due
4 May 2027
Last conf. stmt
20 April 2026

Charges

Total
1
Outstanding
0
Part satisfied
0
Satisfied
1

Officers 5 active

Officer details are public data from the Companies House register.

Director · Appointed 1 May 2023
Also at Glaxosmithkline Capital PLC, GSK PLC, GSK Finance (No 2) Limited · more companies
British
Born March 1962 (64)
Director · Appointed 7 May 2019
Also at Glaxosmithkline Intellectual Property Holdings Limited, Glaxosmithkline Intellectual Property Limited, Smithkline Beecham Legacy H Limited · more companies
British
Born November 1967
Secretary · Appointed 17 April 2001
Also at GSK PLC, Beecham Group PLC, Glaxo Group Limited · more companies
British
Corporate Director · Appointed 31 January 2001
Also at British Pharma Group Limited, Beecham Group PLC, Dealcyber Limited · more companies
Corporate Director · Appointed 31 January 2001
Also at Beecham Group PLC, Dealcyber Limited, Glaxo Wellcome Investments B.V. · more companies
Officer history (38 former)
1 May 2023
Appointed Brown, Julie Belita as Director
1 May 2023
Resigned Mackay, Iain James as Director
20 June 2019
Appointed Mackay, Iain James as Director
7 May 2019
Appointed Walker, Adam as Director
1 May 2019
Resigned Dingemans, Simon Paul as Director
1 April 2011
Appointed Dingemans, Simon Paul as Director
31 March 2011
Resigned Heslop, Julian Spenser as Director
28 February 2011
Resigned Bicknell, Simon Michael as Secretary
9 September 2009
Appointed Heslop, Julian Spenser as Director
31 March 2005
Resigned Coombe, John David as Director
22 March 2002
Resigned Ingram, Robert Alexander as Director
22 March 2002
Resigned Sykes, Richard Brook, Sir as Director
15 July 2001
Resigned Niedel, James Edward, Doctor as Director
17 April 2001
Appointed Whyte, Victoria Anne as Secretary
20 February 2001
1 February 2001
Resigned Barzach, Michele, Dr as Director
31 January 2001
Appointed Bicknell, Simon Michael as Secretary
31 January 2001
Resigned Bicknell, Simon Michael as Secretary
31 January 2001
Resigned Cowden, Stephen John as Secretary
31 January 2001
Resigned Cochrane, James Michael Thomas as Director
31 January 2001
Appointed Edinburgh Pharmaceutical Industries Limited as Corporate Director
31 January 2001
Resigned Mcarthur, John Hector, Dean as Director
31 January 2001
Appointed Glaxo Group Limited as Corporate Director
29 January 2001
Resigned Job, Peter James Denton, Sir as Director
29 January 2001
Resigned Hurn, Francis Roger, Sir as Director
26 January 2001
Resigned Bonham, Derek Charles as Director
31 December 2000
Resigned Strachan, Jeremy Alan Watkin as Director
27 December 2000
Resigned Li, Arthur Kwok Cheung as Director
17 May 1999
7 November 1997
Resigned Lance, Sean Patrick as Director
1 October 1997
Appointed Job, Peter James Denton, Sir as Director
19 May 1997
Resigned Corness, Colin Ross, Sir as Director
19 May 1997
Resigned Armstrong, Anne Armant Legendre as Director
5 January 1997
1 January 1997
Appointed Li, Arthur Kwok Cheung as Director
1 January 1997
Appointed Barzach, Michele, Dr as Director
1 January 1997
Appointed Schmitz, Ronaldo Hermann, Doctor as Director
20 December 1996
Resigned Aberavon, Howe Of, Lord as Director
1 September 1996
Appointed Hurn, Francis Roger, Sir as Director
19 May 1996
Resigned Derx, Donald John as Director
5 March 1996
Appointed Mcarthur, John Hector, Dean as Director
1 February 1996
Appointed Bicknell, Simon Michael as Secretary
1 February 1996
Appointed Cowden, Stephen John as Secretary
1 February 1996
Resigned Morris, Nicholas Guy Usher as Secretary
17 November 1995
Resigned Cuckney, John Graham, Lord as Director
17 November 1995
Resigned Ferguson, James Larnard as Director
1 July 1995
Appointed Bonham, Derek Charles as Director
1 July 1995
Appointed Cochrane, James Michael Thomas as Director
1 July 1995
Appointed Niedel, James Edward, Doctor as Director
30 June 1995
Resigned Maidment, Neil as Director
17 May 1995
Resigned Sanders, Charles Addison, Dr as Director
17 May 1995
Appointed Ingram, Robert Alexander as Director
3 January 1995
Resigned Konishi, Hiroshi as Director
1 December 1994
Resigned Humer, Franz Bernhard as Director
18 November 1994
Appointed Corness, Colin Ross, Sir as Director
18 November 1994
Resigned Girolami, Paul, Sir as Director
31 March 1994
Resigned Hignett, John Mulock as Director
16 February 1994
Resigned Pappas, Arthur Menelaus as Director
1 October 1993
10 March 1993
Resigned Mario, Ernest as Director
1 March 1993
Appointed Lance, Sean Patrick as Director
1 March 1993
Appointed Maidment, Neil as Director
16 October 1992
Resigned Dahrendorf, Ralf, The Lord as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Public Limited Company
Reg. no. 3888792

Group structure 22 shown

Ownership group derived from the Companies House PSC register

GSK PLC
British Pharma Group Limited Holds 25–50% of voting rights
Glaxosmithkline Holdings (One) Limited Owns 75–100% of shares
Glaxosmithkline Holdings Limited Owns 75–100% of shares
Glaxosmithkline Finance PLC Owns 75–100% of shares
Glaxo Group Limited Owns 75–100% of shares
Glaxosmithkline Ihc Limited Owns 75–100% of shares
GSK Finance (No 2) Limited Owns 75–100% of shares
Setfirst Limited Owns 75–100% of shares
Smithkline Beecham Limited Owns 75–100% of shares
Wellcome Limited Owns 75–100% of shares
Glaxosmithkline Mercury Limited Owns 75–100% of shares
Viiv Healthcare Limited Owns 75–100% of shares
Viiv Healthcare Finance 2 Limited Owns 75–100% of shares
Viiv Healthcare Overseas Limited Owns 75–100% of shares
Viiv Healthcare Trading Services UK Limited Owns 75–100% of shares
Viiv Healthcare UK (No.4) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.5) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.6) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.7) Limited Owns 75–100% of shares
Viiv Healthcare UK Limited Owns 75–100% of shares
Glaxosmithkline Services Unlimited This company Owns 75–100% of shares

Filings 2183

DateDescriptionMade Up ToPagesPDF
10 August 2026Full accounts31 December 2025
20 April 2026Confirmation statement with no updates20 April 2026
18 August 2025Full accounts31 December 2024
4 August 2025Confirmation statement with no updates4 August 2025
23 September 2024Secretary's details changed
Show all 2183 filings

Some other companies at this address

Allen & Hanburys Limited
Beecham Group PLC
Berkeley Square Common Investment Fund (No. 2) Limited
Berkeley Square Common Investment Fund Limited
British Pharma Group Limited
Burroughs Wellcome International Limited

Other companies in this industry

London
Christchurch
Peterborough
Enfield
London
Southend-On-Sea

By trade and location

New companies in London →

Explore the largest companies

Largest companies in London, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?